The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AXIM Detailed Price Forecast - CNN Money||View AXIM Detailed Summary - Google Finance|
|View AXIM Detailed Summary - Yahoo! Finance||View AXIM Stock Research & Analysis - Zacks.com|
|View AXIM Trends & Analysis - Trade-Ideas||View AXIM Major Holders - Barrons|
|View AXIM Call Transcripts - NASDAQ||View AXIM Breaking News & Analysis - Seeking Alpha|
|View AXIM Annual Report - CompanySpotlight.com||View AXIM OTC Short Report - OTCShortReport.com|
|View AXIM Fundamentals - TradeKing||View AXIM SEC Filings - Bar Chart|
|View Historical Prices for AXIM - The WSJ||View Performance/Total Return for AXIM - Morningstar|
|View the Analyst Estimates for AXIM - MarketWatch||View the Earnings History for AXIM - CNBC|
|View the AXIM Earnings - StockMarketWatch||View AXIM Buy or Sell Recommendations - MacroAxis|
|View the AXIM Bullish Patterns - American Bulls||View AXIM Short Pain Metrics - ShortPainBot.com|
|View AXIM Stock Mentions - StockTwits||View AXIM Stock Mentions - PennyStockTweets|
|View AXIM Stock Mentions - Twitter||View AXIM Investment Forum News - Investor Hub|
|View AXIM Stock Mentions - Yahoo! Message Board||View AXIM Stock Mentions - Seeking Alpha|
|View Insider Transactions for AXIM - SECform4.com||View Insider Transactions for AXIM - Insider Cow|
|View AXIM Major Holdings Summary - CNBC||View Insider Disclosure for AXIM - OTC Markets|
|View Insider Transactions for AXIM - Yahoo! Finance||View Institutional Holdings for AXIM - NASDAQ|
|View AXIM Stock Insight & Charts - FinViz.com||View AXIM Investment Charts - StockCharts.com|
|View AXIM Stock Overview & Charts - BarChart||View AXIM User Generated Charts - Trading View|
FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy
Posted on Wednesday June 05, 2019
AXIM® Biotechnologies, Inc. (AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has garnered news coverage for an opinion article in top U.S. consumer publication FOX Business. The article was co-authored by John W. Huemoeller II, the Company’s CEO, and Dr. Stuart Titus, CEO of Medical Marijuana Inc., the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products.
AXIM® Biotechnologies, Inc. (AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has signed a cannabinoid product supply agreement with Impression Healthcare Limited (“Impression”) for the supply of the Company’s toothpaste and mouthwash containing cannabidiol (CBD) for its clinical trial for the treatment of periodontitis.
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing
Posted on Friday May 17, 2019
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...
AXIM® Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company
Posted on Wednesday May 15, 2019
NEW YORK, May 15, 2019 -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “AXIM”, or the “Company”), a world leader in cannabinoid research and development, today.